AI assistant
Sending…
UroGen Pharma Ltd. — Director's Dealing 2019
Jan 15, 2019
32312_dirs_2019-01-15_41624f5f-c2fb-45d8-8c8e-ba1c1c692642.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3/A — Form 3/A
Issuer: UroGen Pharma Ltd. (URGN)
CIK: 0001668243
Period of Report: 2019-01-01
Reporting Person: Holden Stuart (Director)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $5.94 | 2022-12-10 | Ordinary Shares (48000) | Direct |
Footnotes
F1: 33.33% of the shares underlying the stock option vested on each of December 10, 2016, December 10, 2017 and December 10, 2018.
More from UroGen Pharma Ltd.
Annual Report
2026
May 27
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Proxy Solicitation & Information Statement
2026
Apr 30
Annual Report
2026
Mar 2
Regulatory Filings
2026
Mar 2
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 11